Review Articles

All of these articles have Matthew either as primary author or a corresponding author. Papers are sorted in descending order within each section.

2021-2025

• Hayes & Meyerson. Molecular portraits of lung cancer evolution. Nature. 2023 Apr;616(7957):435-436.​
• Sanders BE, Qiao G, Hirschman J, Meyerson M. Fusobacterium and Colorectal Cancer: Important Association or Random Coincidence? Cancer Res. 2022 Oct 17;82(20):3671-3672.
• ​Aquilanti E, Kageler L, Wen PY, Meyerson M. Telomerase as a therapeutic target in glioblastoma. Neuro Oncol. 2021 Dec 1;23(12):2004-2013.

2016-2020

• Zhang X, Meyerson M. Illuminating the noncoding genome in cancer. Nat Cancer. 2020 Sep;1(9):864-872.
• Bullman S, Meyerson M, Kostic AD. Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease. Annu Rev Pathol. 2017 Jan 24;12:217-44. PMID: 27959634.
• Bullman S, Zou T, Meyerson M. Mechanistic Insights into Transmissible Cancers of Mammals. Cancer Cell. 2018 Apr 9;33(4):543-44. PMID: 29634941
• Bandopadhayay P, Meyerson M. Landscapes of Childhood Tumours. Nature. 2018;555;316-17. PMID: 29542703
• Zou T, Meyerson M. Circulating Tumor DNA Provides a Sneak Peek into Treatment Responses in Non-Small Cell Lung Cancer. Cancer Res. 2019 Mar 15;79(6):1038-1040. PMID: 30877100.
• Meyerson M. Bacterial invaders drive CRC progression. Sci Signal. 2020 Aug11;13(644):eabc4218. PMID: 32788340.

2011-2015

• Francis J, Lin W, Rozenblatt-Rosen O, Meyerson M. The menin tumor suppressor protein is phosphorylated in response to DNA damage. PLoS One. 2011 Jan 14;6(1):e16119. PMID: 21264250;   PMCID: PMC3021530.
• Meyerson M, Pellman D. Cancer genomes evolve by pulverizing single chromosomes. Cell. 2011 Jan 7;144(1):9-10.  PMID: 21215363.
• Chin L, Hahn WC, Getz G, Meyerson M. Making sense of cancer genomic data. Genes Dev. 2011 Mar 15;25(6):534-55.  PMID: 21406553; PMCID: PMC3059829 .
• Macconaill LE, Van Hummelen P, Meyerson M, Hahn WC. Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges. Cancer Discov. 2011 Sep 1;1(4):297.  PMID: 21935500;   PMCID: PMC3175123.
• Jänne PA, Meyerson M. ROS1 Rearrangements in Lung Cancer: A New Genomic Subset of Lung Adenocarcinoma. J Clin Oncol. 2012 Mar 10;30(8):878-9. Epub 2012 Jan 3.  PMID: 22215755.
• Liao RG, Watanabe H, Meyerson M, Hammerman PS. Targeted therapy for squamous cell lung cancer. Lung Cancer Manag. 2012 Dec;1(4):293-300. PMID:23956794,   PMCID: PMC3744181.
• Watanabe H, Meyerson M. Hopping between Differentiation States in Lung Adenocarcinoma. Cancer Cell. 2013 Jun 10;23(6):707-9. PMID: 23763994; PMCID: PMC3748274.
• Kostic AD, Chun E, Meyerson M, Garrett WS. Microbes and inflammation in colorectal cancer. Cancer Immunol Res. 2013 Sep;1(3):150-7. PMID: 24777677.
• Chmielecki J, Meyerson M. DNA Sequencing of Cancer: What Have We Learned? Annu Rev Med. 2014;6563-79. PMID: 24274178.
• Watanabe H, Brooks AN, Meyerson M. Breaking down RET breakpoints in lung adenocarcinoma. J Thorac Oncol. 2014 May;9(5):590-2. PMID: 24722148; PMCID: PMC4036692.

2006-2010

• Thomas RK, Weir B, Meyerson M. Genomic approaches to lung cancer. Clin Cancer Res. 2006;12:4384s-91s. PMID: 16857815
• Meyerson M. Cancer: broken genes in solid tumours. Nature. 2007 Aug 2;448(7153):545-6. PMID: 17671492
• MacConaill L, Meyerson M. Adding pathogens by genomic subtraction. Nat Genet. 2008 Apr;40(4):380-2. PMID: 18368124
• Wistuba II, Meyerson M. Chromosomal deletions and progression of premalignant lesions: less is more. Cancer Prev Res (Phila). 2008 Nov;1(6):404-8. PMID: 19138986
• Bass AJ, Meyerson M. Genome-wide association study in esophageal squamous cell carcinoma. Gastroenterology. 2009 Nov;137(5):1573-6. PMID: 19789091.
• Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010 Oct;11(10):685-96. Review.  PMID: 20847746.

2000-2005

• Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol. 2000;18(13):2626-34. PMID: 10893296
• Hahn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med. 2001;33(2):123-9. PMID: 11327115
• Meyerson M. Human genetic variation and disease. Lancet. 2003 Jul 26;362(9380):259-60. PMID: 12892951
• Meyerson M, Franklin WA, Kelley MJ. Molecular classification and molecular genetics of human lung cancers. Semin Oncol. 2004;31(1Suppl 1):4-19. PMID: 14981576.
• Dubinett SM, Elashoff D, Meyerson M. Assessing prognosis in non small-cell lung cancer avenues to a more complete picture? J Clin Oncol. 2004;22(16):3209-11. PMID: 15249586
• Weir B, Zhao X, Meyerson M. Somatic alterations in the human cancer genome. Cancer Cell. 2004. Nov;6(5):433-8. PMID: 15542426.
• Meyerson M, Carbone D. Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clinical Oncol. 2005. May 10;23(14):3219-26. PMID: 15886309
• Sellers WR, Meyerson M. EGFR gene mutations: a call for global x global views of cancer. J Natl Cancer Inst. 2005;97(5):326-8. PMID: 15741561

Pre-2000

• ​Meyerson M. Telomerase enzyme activation and human cell immortalization. Toxicol Lett. 1998;102-103:41-5. PMID: 10022230